Recent news on 5-Aminosalicylic Acid

DDW: A Bit of Good News for Rosiglitazone (Avandia), With ...  -  May 21, 2007
MedPage Today,The first line of treatment for the disease is drugs containing 5-aminosalicylic acid, but some patients either don't respond or can't take those

New Prevention, Treatment Methods For Patients With Painful Bowel ...  -  May 23, 2007
Medical News Today (press release),Currently, 5-aminosalicylic acid (5-ASA) is the most common treatment for ulcerative colitis (UC), a form of inflammatory bowel disease (IBD).

Ligand rosiglitazone for active ulcerative colitis  -  May 22, 2007
SpiritIndia,Currently, 5-aminosalicylic acid (5-ASA) is the most common treatment for ulcerative colitis (UC), a form of inflammatory bowel disease (IBD).

Salix Pharmaceuticals Reports 4Q2006 and FY2006 Results  -  Feb 28, 2007
Business Wire (press release),This is solid growth in relation to the branded 5- aminosalicylic acid, or 5-ASA, market which increased 4% during the same period. In terms of prescription

Current and Emerging Strategies in Biologic Therapy for IBD  -  Dec 4, 2006
Medscape (subscription)...progresses from the use of 5-aminosalicylic acid, antibiotics, and steroids on through immunomodulators and culminates with anti-TNF-alpha therapy.

This site is for informational purposes only--it does not offer medical advice or sell health products. If you need assistance, contact your physician or healthcare professional